Investing.com2d agobullish
Hims & Hers stock climbs on direct partnership with Eli Lilly for obesity drugsNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Bloomberg48d agobearishVIDEO
Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock MoversBarrons.com48d agoneutral
Why Novo Stock Is Dropping After Drugmaker Unveils Ambitious Growth PlanInvestorsHub55d agoneutral
Novo Nordisk Adopts Novo as Everyday Operating Name and Introduces New Cultural FrameworkGuruFocus.com68d agoneutral
Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in GermanySimply Wall St.111d agoneutral
Novo Nordisk (CPSE:NOVO B) Launches Kyinsu In China Through Fangzhou Internet HospitalSimply Wall St.141d agoneutral
Novo Nordisk (NYSE:NVO) Launches Pan European Obesity Research Push As Pfizer Closes InSimply Wall St.141d agoneutral
Novo Nordisk (CPSE:NOVO B) Launches CardioMetabolic Bridge To Speed New Obesity And Diabetes TherapiesGuruFocus.com142d agobullish
Novo Nordisk Stock Rally as Owner Unveils $69 Million Obesity Research Push